Navigation Links
Chemotherapy Pill Has Fewer Side Effects Than IV,,

A chemotherapy pill is as effective for treating advanced colorectal cancer as intravenous treatment with a similar drug. Patients taking the pill capecitabine survived just as long as those on standard chemotherapy, but the pill caused fewer side effects.// Capecitabine is the oral form of 5-fluorouracil (5-FU), the chemotherapy regimen most commonly used to treat advanced colorectal cancer.

Capecitabine is both convenient to use and produces fewer side effects, and that's a big attraction for patients. Given these results, patients slated to receive the chemotherapy drug 5-FU could consider receiving it in pill form rather than through an IV.

Capecitabine, sold as Xeloda by New Jersey-based Roche Laboratories, has been approved by the FDA to treat breast cancer that has spread beyond the breast and is resistant to standard chemotherapy. Unlike intravenous 5-FU, which is active throughout the body, capecitabine is designed to target tumor cells directly.

Patients taking the oral drug were significantly more likely to respond to treatment than those on standard chemotherapy, and side effects, including diarrhoea, hair loss, nausea and gastrointestinal tract ulcers, were less common in patients taking the pill, particularly during the first few months of treatment. Patients in the capecitabine group were also less likely to be hospitalized due to side effects.
'"/>




Page: 1

Related medicine news :

1. Acupuncture May Help Chemotherapy Side Effects
2. Survival rates in breast cancer patients improved with "Dose Dense Chemotherapy"
3. Therapy Boosts Chemotherapy Effects
4. Chemotherapy Effective for Bladder Cancer
5. New Method Of Delivering Chemotherapy
6. The Benefits Of Chemotherapy For Women With Ovarian Cancer
7. New Compound Could Strengthen The Effect Of Chemotherapy
8. Older Breast Cancer Patients Can Be Effectively Treated With Chemotherapy
9. Treating Testicular Cancer With A Single Dose Of Chemotherapy
10. Ginger Found To Reduce Nausea Associated With Chemotherapy
11. AIDS Drug Found To Help Patients Undergoing Chemotherapy
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... October 13, 2017 , ... ... Randall, PharmD ‘17, and Jennifer Huggins, PharmD ’17, along with clinical associate ... primary prevention of cardiovascular diseases during the 15th Annual Women’s Health Conference. ...
(Date:10/13/2017)... LUIS OBISPO, Calif. (PRWEB) , ... October 13, 2017 , ... ... Alzheimer’s or dementia. However, many long-term care insurance companies have a waiver for care ... is the 90-day elimination period, when the family pays for care, is often waived, ...
(Date:10/13/2017)... ... 2017 , ... Global Healthcare Management’s 4th Annual Kids Fun Run brought out ... free event, sponsored by Global Healthcare Management’s CEO, Jon Letko, is aimed at getting ... children of all ages; it is a non-competitive, non-timed event, which is all about ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... Agile Software Development, has been awarded a contract by the Center for Medicare ... (BPA) aims to accelerate the enterprise use of Agile methodologies in a consistent ...
(Date:10/12/2017)... Del. (PRWEB) , ... October 12, 2017 , ... ... and advisory services for healthcare compliance program management, will showcase a range of ... National Association for Assisted Living (NCAL) Convention and Expo to be held October ...
Breaking Medicine News(10 mins):
(Date:9/23/2017)... , Sept. 22, 2017 Janssen Biotech, ... complete response letter from the U.S. Food and Drug ... approval of sirukumab for the treatment of moderately to ... indicates additional clinical data are needed to further evaluate ... to severely active RA. ...
(Date:9/19/2017)... 19, 2017   ZirMed Inc ., a recognized leader ... that it has been ranked #1 by its users for ... Rankings 2017 User Survey. ZirMed was recognized as the top-ranked ... and medical centers over 200 beds and holds one of ... user survey history. ...
(Date:9/12/2017)... and NEW YORK , Sept. 12, 2017 ... performance ratings for global supply chains, has published the first annual edition ... CSR performance of more than 20,400 companies evaluated by EcoVadis, based on ... 2015 and 2016. ... EcoVadis Global CSR Risk & Performance Index ...
Breaking Medicine Technology: